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Summary. From 1986 until 1990, in vivo proliferation 
rates (PRs) in 110 patients with renal-cell carcinoma 
(RCC) were immunohistochemically determined by the 
Ki-67 assay. It could be demonstrated that the PRs of 
RCCs range between only 1% and 15%. Due to its low 
proliferative kinetics in vivo, tumor cytogenetic nvestiga- 
tions of this malignancy remain rare. During short-term 
in vitro culture, the PRs of this neoplasm increased 
(21%-  82%). Therefore, 36 untreated human RCCs were 
cultured in vitro for cytogenetic analysis using the G- 
banding technique. In all, 77.8% (28/36) of the renal ma- 
lignancies investigated exhibited an aberration of 
chromosome 3, which seems to serve as a marker for this 
malignancy. Whereas tumor stage showed no correlation 
with PR, tumor grade exhibited a strong correlation with 
this parameter. According to the data presented herein, 
immunohistochemical determination of the tumor-spe- 
cific PR using the monoclonal antibody Ki-67 is a practi- 
cable, reliable and reproducible method that comple- 
ments conventional histological tumor grading and stag- 
ing. This parameter appears to be useful in identifying 
RCC patients at high risk, especially at early stages that 
are identical in tumor stage and grade. 
For > 100 years, pathologists and clinicians have been en- 
gaged in examining proliferative patterns and behaviour 
of human malignancies as compared with normal tissue. 
This is necessary for a better understanding of pathogen- 
esis, therapeutic principles and individual prognosis. 
Flamming (1882) and Waldeyer (1888) were the first in- 
vestigators to describe the histomorphological concep- 
tion of "cell division, mitosis and cell proliferation" in 
human malignancies [8]. In different malignant umors, 
pathologists have found a correlation between the mitosis 
rate determined in histological specimens and the individ- 
ual clinical course of patients with neoplasias [10, 18]. 
* To whom correspondence should be ad ressed 
Mitosis, however, represents only a short phase in the ac- 
tive'cell cycle. Microscopically, only 1 °7o - 5% of all DNA- 
synthesizing cells are detectable in histological specimens 
[15, 17]; therefore, this can be regarded only as an indirect 
parameter of the proliferative pattern of the tissue. 
It took a long time for the direct detection of tumor- 
specific proliferation rates (PRs) to become possible. By 
autoradiographic studies using the thymidine incorpora- 
tion assay, direct measurement of the portion of DNA- 
synthesizing cells was achieved for the first time. In 1979 
Rabes and co-workers [15] presented a clinical report of 
PRs in renal-cell carcinoma (RCC) using this technique. 
These authors found low PRs (< 2007o) and a correlation 
between PR and recurrence rate in a series of ten RCC pa- 
tients. The main disadvantages o}" this method, however, 
involve (a) the extracorporeal organ perfusion (ex vivo) 
required after tumor nephrectomy, (b) the exposure of pa- 
tients to radioactivity and, thus, (c) the lack of practica- 
bility of the technique in routine diagnosis. 
The successful preparation of monoclonal antibodies 
represented a relevant advance in this area [12]. In 1983 
Gerdes et al. [5] isolated and characterized a human nu- 
clear antigen (termed Ki-67) present only in DNA-synthe- 
sizing cells; its expression is laresent in normal as well as 
in malignant cells but is absent from resting cells [7]. Us- 
ing frozen sections and immunohistochemical staining 
techniques as outlined by Gerdes et al. [6] and Cordell et 
al. [4], individual in vivo PRs in normal and malignant 
tissue can now be obtained directly. 
In recent years an increasing number of chromosomal 
aberrations have been described in human hematopoietic 
neoplasms [13, 23]. This finding emerges from the pro- 
liferative behaviour and the high mitotic rates of these 
malignancies in vivo. Because of the low spontaneous PR 
in vivo (only up to 15°70), tumor cytogenetic investiga- 
tions of human RCC remain rare [16, 22]. Direct in vivo 
preparation of malignant renal tissue obtains only a few 
mitotic cells; furthermore, karyotyping of the cells is im- 
paired by irregular contractions of the chromosomes [1]. 
In the present study, the technique of in vitro preparation 
of human RCC is described, which enables the attain- 
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ment of higher numbers of proliferative malignant cells 
and, thus, reproducible chromosomal findings. Further- 
more, individual in vivo PRs are correlated with conven- 
tional tumor stage and grade as well as with the clinical 
courses of the corresponding RCC patients. 
Table 1. Tumor stage and grade of the 36 RCCs investigated for in 
vivo/in vitro PRs and cultured in vitro for tumor cytogenetic analysis 
Patients 
(n) (%) 
Patients and methods 
A total of 110 patients with RCC who showed no evidence of metastatic 
disease at the time of surgery (N 0, M 0 according to imaging tech- 
niques) entered this ongoing study for measurement of individual PRs 
in vivo. Successful short-term in vitro culture and banding analysis was 
successful in 36 of 47 cases (76.6%). The in vivo/in vitro PRs were com- 
pared in all 36 of these instances. Table 1 illustrates tumor staging and 
grading of the 36 cases of RCC analysed. 
• Normal and malignant renal tissues were obtained by conventional 
radical nephrectomy. A macroscopically homogeneous area that was 
free of fibrosis, necrosis or haemorrhage of the tumor was excised for 
preparation. Figure 1 exhibits chematically the tumor cell preparation. 
Samples of excised normal and malignant renal tissue were taken for in 
vitro cell preparation, and other samples were obtained for histological 
examination as reference slides (H&E staining). Furthermore, samples 
were stored in fluid nitrogen for frozen sectioning followed by immuno- 
histochemical nalysis and measurements of the in vivo PRs as de- 
scribed elsewhere [6]. 
Preparation of primary cell cultures according to the
cell-cluster technique 
After mincing and enzymatic treatment with collagenase, the fragments 
of fresh tissue were centrifuged and washed twice in RPMI I640 medi- 
um. Subsequently, the tissue clusters were resuspended in a centrifuge 
tube containing 2 -4  ml culture medium (RPMI 1640 supplemented 
with 15% foetal calf serum and 1% penicillin) and vigorously dispersed 
by means of a Pasteur pipette. The suspension was allowed to sediment 
for 1 rain, and the supernatant containing >90% of the single cells with 
low viability and cell debris was decanted. The pellet, whose content 
comprised by >90% small clusters of approximately 10-15 cells each, 
was resuspended and seeded in culture. The cell clusters were incubated 
at 37 °C in a humidified atmosphere containing 5% CO 2 in 25-cm 2Fal- 
con flasks (Biochrom, Berlin, FRG), to each of which 5 ml culture me- 
dium had been added. The small cell clusters attached to the flasks 
within 24 h and grew to an almost confluent monolayer, in most cases 
within 7 -14 days of cell culture [13, I7]. 
Chromosome analysis 
Cytogenetic analysis was carried out on days 7 -14  of primary culture, 
depending on the proliferation of the tumor cells. In all, 0.1-0.2 ixg/ml 
Specimen for reference histology 
and frozen sections 
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Fig. 1. Schematic representation of tumor-cell preparation for in vitro 
culturing and cytogenetic analysis 
Stage 
pT 1 - 2 9 25 
pT 3 23 63.9 
pT 4 4 11.1 
Grade 
G 1 11 30.6 
G 2 l0 27.8 
G 3 15 41.6 
colchicine (30-60 min) or 0.02 pg/ml colcemid (2-3 h) was added to 
the cell cultures. The cells were detached 5y 0.025% trypsin- 
ethylenediaminetetraacetic acid (EDTA) solution and then treated with 
0.075M potassium chloride solution for 15-30rain. After this 
hypotonic treatment, he cells were fixed two or three times with cold 
methanol-acetic a id (3:1, v/v). Chromosome preparations were ob- 
tained using the air-drying technique .and the slides were kept at room 
temperature for 3 - 5 days before banding. Karyotype analysis was rou- 
tinely performed using the (GTG) [20] and (CBG) techniques [21] and, 
in some cases, the (.QFQ) technique [2] for the identification f the Y 
chromosome. Up to 15 metapbases were karyotyped in each case, with 
only well-banded metaphases being karyotyped according to the Inter- 
national System for Cytogenetic Nomenclature (ISCN) [11]. 
Analysis of the constitutional karyotype 
To define the constitutional karyotype of the patients, normal kidney 
tissues were prepared for in vitro cultures in the same manner described 
above for tumor samples. Cytogenetic analysis was carried out by the 
same procedure. When normal renal tissue was not available or normal 
renal cells did not grow in vitro, phytohaemagglutinin-stimulated pe- 
ripheral blood lymphocytes were karyotyped. 
Preparation of in vivo and in vitro slides 
for determination of PRs 
As outlined above, normal and malignant renal tissues were stored in 
fluid nitrogen. Frozen sections were prepared for the immunohisto- 
chemical Ki-67 assay as described by Gerdes and co-workers [6] so as 
to obtain the in vivo PR directly. Furthermore, cells of the primary cell 
culture that had been transferred to cell-culture flasks were directly 
placed in special in vitro slide chambers (Fig. 2; NUNC Company, 
Wiesbaden, FRG). On the day during which the chromosomal nalysis 
began, the in vitro slides were also stained for immunocytochemical 
Ki-67 assay [6, 16]. 
Fig. 2. Slide chamber for in vitro growth of malignant renal cells 
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Fig. 3. Immunohistochemical in 
vivo staining of an undifferentiat- 
ed RCC using the Ki-67 tech- 
nique. Positive c lls are stained 
darkly. PR, 15°70; original 
magnification, x I20 
Fig. 4. In vitro short-term cell cul- 
ture of the same RCC illustrated 
in Fig. 3, showing immunocyto- 
chemical staining obtained using 
mAb Ki-67. PR, 8207o; original 
magnification, x 80 
Gerdes and colleagues [5, 7] provided the monoclonal antibody 
Ki-67, which binds to a human nuclear antigen associated with cell pro- 
liferation. Cell-cycle analyses demonstrated that this nuclear antigen 
was detected by Ki-67 only in the G~, S, G 2 and M phases of proliferat- 
ing cells, regardless of viability, but not in G o cells [7]. Thus, the Ki-67 
assay established an easy, fast and reproducible method of determining 
the growth fractions of tumors in vivo [6] as well as in vitro [16]. The 
Ki-67 staining method was performed as follows. The acetone- and 
chloroform-fixed cells were xposed for approximately 30rain to mono- 
clonal antibody that had been diluted in RPMI 1640 medium. After 
washing in TRIS-buffered solution (pH 7.4-7.6), the cells wei'e incubat- 
ed with rabbit-anti-mouse IgG and then exposed to APAAP (alkaline 
phosphatase anti-alkaline phosphatase) complex after another washing 
[4]. Subsequently, the slides were stained with fast red and counterstain- 
ed with hemalum [6, 16]. Presence of the specific antigen was indicated 
by a red instead of a blue color reaction after counterstaining. 
Results 
Table 1 del ineates the h isto logical  grade and stage o f  all 
36 RCCs  assigned to this study. As demonstrated,  cultur-  
ing o f  not  only  undi f ferent iated tumors  but  also low- 
grade RCCs  was successful.  The  success rate for in vitro 
culture was 87.2o70 (41/47), but  correct band ing  for tu- 
mor  cytogenet ic  analysis succeeded in on ly  36 cases 
(76.6O7o). Whereas  normal  renal tissue showed PRs o f  
a round 1% and wel l -d i f ferent iated RCC tumors  exhibited 
PRs  ranging between 1 °7o and 3o70, poor ly  d i f ferent iated 
tumor  tissues showed values o f  up to 15o7o (Fig. 3). Fol- 
lowing in vitro culture, PRs  o f  ma l ignant  renal t issues in- 
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Fig. 5. Schematic representation of a normal 
chromosome 3 according to the ISCN classifi- 
cation [11] 
creased considerably, ranging between 21o70 and 82°70 
(Fig. 4). 
Figure 5 gives a schematic representation of a normal 
chromosome 3. Figure 6 illustrates the G-banded karyo- 
type of an in vitro cultured RCC, showing a deletion of 
the short (19) arm of chromosome 3, which was the chro- 
mosome most involved in tumor-induced aberrations. In 
28 (77.8°70) of the 36 RCCs analysed, various aberrations 
on chromosome 3 were observed, including deletion of 
the short arm or translocation of different chromosomal 
segments to the deletion-altered portion of the chrom- 
some. Six tumors exhibited aberrations on chromosome 
3 exclusively, showing no changes in other chromosomes 
(Fig. 7). In 22.207o f the cases (8/36), aberrations on 
chromosomes other than chromosome 3 were observed 
(Fig. 8). Chromosomal aberrations were noted neither in 
normal kidney cells nor in peripheral blood lymphocytes. 
As illustrated in Fig. 9, the shortest possible interval 
between sampling and storage of the specimens is essen- 
tial for the correct determination of individual PRs. 
Rates measured at 3.5h after tumor nephrectomy 
amounted to only approximately 50% of those initially 
determined. 
The determination of the percentage of Ki-67-positive 
cells was performed as described by Gerdes et al. [6]. To 
exclude sampling errors, several samples of solid tumor 
tissue must be obtained, depending on the individual tu- 
mor size (Table 2). The highest PR found for all speci- 
Fig. 6. G-banded karyotype of an RCC cultured in vitro; note the deletion of both short (p) arms of chromosome 3 (arrow) 
Table 2. Number of specimens according to tumor size for represen- 
tative measurement of PRs 
Tumor size Specimens (n) 
Peripheral Central 
<3 cm 2 1 
3 -6  cm 4 2 
>6 cm 6 2 
Proliferation rates: peripheral> central 
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mens analysed in a given case was considered to be repre- 
sentative of the entire tumor. 
From 1986 until 1990, PRs in 110 patients with RCC 
were immunohistochemically measured using the Ki-67 
assay. As determined using histology and imaging tech- 
niques, these patients howed no evidence of metastatic 
spread at the time of tumor nephrectomy. Table 3 gives an 
overview of the PR, histological tumor staging (pT) and 
grading (G) of the 110 cases investigated. The classifica- 
1 :2 3 4 5 
6 7 8 9 10 11 12 
13 14 t5 
7 19 
~ - ' J l ' !  
20 21 22  = XX 
Fig. 7. Another case of a 
karyotyped RCC; deletion of one 
short (!0) arm of chromosome 3 is 
the only aberration (arrow) 
Fig. 8. G-banded karyotype of an RCC cultured in 
vitro; note the 2 normal chromosomes 3 combined 
with trisomy of chromosomes 7 and 17 
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Table 3. Correlation of tumor stage and grade with PRs 
PRs (n = 110) a 
0°70 -4°/o >4% -9°70 >9% 
Stage 
pT 1 -2  31 24 16 no 
pT 3 10 17 12 correlation 
Grade 
G 1 25 (74%) 7 2 
G 2 24 12 14 
G 3 3 8 15 /58°7o) 
a 1986-1990, T1 -3 ,  N O , Mo; P<0.001 
v 
'8 
120 - 
100 
80 
60 
40 
20 
0 I I I I I I I 
1 2 3 4 5 6 7 
Time after tumor nephrectomy (h) 
Fig. 9. In vivo PRs plotted against the time of specimen collection 
(mean values of 10 different RCC tumors) 
tion of all RCC tumors was done according to the actual 
(TNM) system of the IUCC (International Union 
Against Cancer) [9]. There was no correlation between 
individual PR and tumor stage (pT; Table 3). In contrast 
to these findings, a strong correlation between PR and tu- 
mor grade was observed (G; Table 3). In low-stage tumors 
(pT1-2), 5-fold variations in PR were measured; we not- 
ed large tumors with low PRs and small tumors (< 3 cm 
in diameter) with PRs of > 9%. 
Thus far, 15 (16.3°70) of the 110 patients investigated 
in the present ongoing study have developed relapsing tu- 
mors (mean follow-up, 2.8 years). In all, 11 cases whose 
tumor recurred during the follow-up period exhibited 
PRs of > 9°70 at the time of tumor nephrectomy; the re-
maining 4 patients howed PRs ranging between 4% and 
9°7o. Three patients with low-stage tumors (pT 1 -2 )  whose 
disease recurred showed PRs of > 9°70. 
Discussion 
RCC occurs spontaneously and is hereditary as well. A 
reciprocal translocation 3; 8 was reported by Cohen et al. 
[3] in ten members of a family that was predisposed to 
RCC. These authors uggested that this chromosomal re- 
arrangement predisposes carriers to develop RCC. Famil- 
ial .RCC is rare; non-familial renal cancer occurs much 
more frequently. However, reports on the cytogenetic fea- 
tures of this disease are scanty. Yoshida et al. [22] and 
other authors [1] have reported on several cases of 
cytogenetic analyses in RCC using short-term in vitro cul- 
tures. Although karyotyping was not described in detail 
in all of the cases, several structural changes in chromo- 
some 3 were observed. 
The in vivo PRs in RCC are low, ranging up to only 
15% as determined by the immunohistochemical Ki-67 
assay (see Fig. 3). Because of this low proliferative poten- 
tial, only a few mitotic cells can be obtained by biopsy; 
furthermore, direct karyotyping of the cells is impaired by 
irregular contractions of the chromosomes [1, 22]. There- 
fore, reports on the chromosomal features of human 
RCC are rare. 
Several authors have described ifferent aberrations 
on chromosome 3 using direct karyotyping of the tumor 
cells [3, 13]. Yoshida et al. [22] were among the first au- 
thors to karyotype malignant renal cells after short-term 
in vitro culture. Following short-term in vitro culture, the 
PRs increase, which improves the cytogenetically 
evaluable output. Malignant renal cells prepared in vitro 
in the manner outlined above were recently characterized 
using conventional cytological, cytochemical nd immu- 
nocytochemical measures [17]. Malignant renal cells were 
exclusively obtained by the cell-cluster preparation tech- 
nique. 
The aberration on chromosome 3 was the most com- 
mon cytogenetic finding in the 36 cases of non-familial 
RCC investigated. None of the patients howed constitu- 
tional aberrations on chromosome 3 of their normal 
cells. Structural changes in chromosome 3 were detected 
in 77.8% (28/36) of cases; these alterations involved the 
loss of different segments of the chromosome. It seems 
that this defect is the initial cytogenetic change and that 
it triggers genetic instability during the clonal develop- 
ment and progression of human RCC. Other non-ran- 
dom and accidental chromosomal changes represent sub- 
sequent events. Our findings thus corroborate the hy- 
pothesis that the deletion of a chromosomal segment 
coding for suppression results in uncontrolled prolifera- 
tion of normal tubular cells. The duration of this phe- 
nomenon accounts for malignant transformation i  cases 
of RCC. These chromosomal aberrations were not ob- 
served in normal cells of the RCC patients; therefore, the 
3p deletion must be an acquired, specific chromosomal 
defect in non-familial RCC. 
According to the data presented herein, chromosome 
3 can be described as the marker chromosome of RCC. 
Becasue the loss of segments on the short arm of chro- 
mosome 3 was not microscopically demonstrable in 8 of 
the 36 tumors, it seems possible that a mutation or loss 
of DNA may take place at a submicroscopic level, analo- 
gous to that demonstrated for retinoblastoma nd 
Wilms' tumor as previously outlined by Kovacs and co- 
workers [13]. Further molecular biology studies, however, 
are required to evaluate the meaning of this specific 
chromosomal defect for the development of RCC. 
As outlined in Fig. 9, fresh tumor tissue must be im- 
mediately stored in fluid nitrogen for correct and reliable 
determination of the tumor-specific PRs. This observa- 
tion correlates with the in vitro growth rates of tumor 
cells, which also essentially depend on the interval be- 
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tween nephrectomy and tissue sampling [17]. Confirming 
the data published by Rabes et al. [15], higher PRs were 
always measured in the peripheral zones of the tumors as 
compared with the central zones. This is obviously nutri- 
tion-related ue to the better blood circulation in the pe- 
ripheral areas. Furthermore, necrosis and cysts initially 
develop in the central zones of tumors, a phenomenon 
that is often observed macroscopically. 
According to the in vivo PRs obtained in the present 
study, it can be concluded that in contrast to tumor stage 
(pT), tumor grade (G) exhibits a strong correlation with 
the individual PR. The individual tumor stage cannot be 
concluded from the PR, as tumor stage is a function of 
cell proliferation as well as of the time of tumor growth, 
with the latter parameter not being measurable at the 
time of diagnosis. Some large RCCs exhibited a low PR. 
These data explain the clinical observation in cases of 
RCC in which, despite a non-surgical approach, for vari- 
ous reasons almost a proliferative arrest is noted at long- 
term follow-up [19]. These in vivo data correspond to the 
PRs previously found in breast cancer by Lelle et al. [14]: 
a positive correlation between histological grading, recur- 
rence rate and PRs was observed as well. 
In conclusion, immunohistochemical determination 
of the tumor-specific PR using the monoclonal antibody 
Ki-67 is a practicable, reliable and reproducible method 
that complements conventional tumor staging and grad- 
ing. Measurement of the individual PRs appears to be an 
additional diagnostic parameter for the detection of RCC 
patients at high risk, especially at early stages showing 
identical histological features. 
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